164 results on '"Armengol, Carolina"'
Search Results
2. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
3. Macrophage CD5L is a target for cancer immunotherapy
4. MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokines
5. Prevalence and outcomes of acute-on-chronic liver failure among cirrhotic patients admitted for an acute decompensation
6. FRI-466-YI Implications and therapeutic potential of neddylation for pediatric liver cancer: hepatoblastoma
7. A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients
8. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
9. CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content
10. Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response.
11. Hepatocellular carcinoma: Present and future
12. Carcinoma hepatocelular: presente y futuro
13. HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosis
14. Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response
15. Pediatric liver cancer: Hepatoblastoma and Neddylation post-translational modification
16. Investigation of novel hepatoblastoma chemosensitizers based on the inhibition of ABC pumps-mediated drug efflux
17. Characterisation of Aberrant Metabolic Pathways in Hepatoblastoma Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS).
18. Supplementary Data from Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
19. Data from Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
20. Supplementary Table 3 from Tbx3 Is a Downstream Target of the Wnt/β-Catenin Pathway and a Critical Mediator of β-Catenin Survival Functions in Liver Cancer
21. Supplementary Figure Legends 1-4 from Tbx3 Is a Downstream Target of the Wnt/β-Catenin Pathway and a Critical Mediator of β-Catenin Survival Functions in Liver Cancer
22. Supplementary Figures 1-4 from Tbx3 Is a Downstream Target of the Wnt/β-Catenin Pathway and a Critical Mediator of β-Catenin Survival Functions in Liver Cancer
23. Supplementary Table 2 from Tbx3 Is a Downstream Target of the Wnt/β-Catenin Pathway and a Critical Mediator of β-Catenin Survival Functions in Liver Cancer
24. Identification ofIGF2as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
25. Abstract IA29: Present and future of precision oncology in hepatoblastoma
26. Abstract PO009: Identification of IGF2 as genomic driver and actionable therapeutic target in hepatoblastoma
27. Abstract PO010: Molecular characterization of pediatric hepatocellular carcinoma: genomic, methylomic and transcriptomic analysis
28. Abstract PO011: Proteomic profiling of childhood liver cancer: identification of novel diagnostic and prognostic biomarkers
29. Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma
30. Molecular classification of hepatoblastoma and prognostic value of the HB 16‐gene signature
31. Development of Hepatoblastoma organoids as a patient-derived ex-vivo system
32. Abstract 4005: Identification of IGF2 as genomic driver and actionable therapeutic target in hepatoblastoma
33. Unravelling the transcriptome of the human tuberculosis lesion and its clinical implications
34. LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways
35. Identification of the most vulnerable populations in the psychosocial sphere: a cross-sectional study conducted in Catalonia during the strict lockdown imposed against the COVID-19 pandemic
36. Identification of important regulatory elements using multi-level matrix factorization approaches
37. Data-driven model for molecular targets and drug repositioning
38. The LIM-only Protein FHL2 Regulates Cyclin D1 Expression and Cell Proliferation
39. Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer
40. Psychosocial impact of the Covid-19 pandemic: Identification of most vulnerable populations
41. SAT-256 - Investigation of novel hepatoblastoma chemosensitizers based on the inhibition of ABC pumps-mediated drug efflux
42. SAT-247 - Pediatric liver cancer: Hepatoblastoma and Neddylation post-translational modification
43. Bridging molecular basis, prognosis, and treatment of pediatric liver tumors
44. Dual inhibition of DNA methyltransferase 1 and the histone methyltransferase G9a as a new therapeutic strategy in hepatoblastoma
45. LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways.
46. O.151 EVIDENCE OF BIPOTENTIAL STEM CELLS IN HEPATOBLASTOMA
47. FRI271 - Development of Hepatoblastoma organoids as a patient-derived ex-vivo system
48. p27 Kip1 is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma
49. Abstract 3107: A scientific task force to generate proof-of-concept data packages for clinical trials in pediatric cancers: The hepatoblastoma example
50. THU-442-Role of drug transporters in the chemoresistance of hepatoblastoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.